SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 208 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $6,112,000 | +24.5% | 242,062 | +21.9% | 0.01% | +16.7% |
Q3 2016 | $4,909,000 | +27.2% | 198,503 | +4.8% | 0.01% | +20.0% |
Q2 2016 | $3,860,000 | +81.7% | 189,480 | +36.0% | 0.01% | +66.7% |
Q1 2016 | $2,124,000 | +6.1% | 139,290 | -6.5% | 0.00% | 0.0% |
Q4 2015 | $2,002,000 | +4.7% | 148,938 | +9.3% | 0.00% | 0.0% |
Q3 2015 | $1,912,000 | -17.9% | 136,268 | -0.7% | 0.00% | 0.0% |
Q2 2015 | $2,330,000 | +125.6% | 137,239 | +60.6% | 0.00% | +200.0% |
Q1 2015 | $1,033,000 | +46.5% | 85,470 | +0.6% | 0.00% | 0.0% |
Q4 2014 | $705,000 | -5.2% | 84,931 | -0.8% | 0.00% | 0.0% |
Q3 2014 | $744,000 | -19.4% | 85,644 | +1.6% | 0.00% | 0.0% |
Q2 2014 | $923,000 | +89.5% | 84,276 | +54.8% | 0.00% | 0.0% |
Q1 2014 | $487,000 | +46.7% | 54,445 | +23.7% | 0.00% | – |
Q4 2013 | $332,000 | +7.1% | 44,025 | +4.0% | 0.00% | -100.0% |
Q3 2013 | $310,000 | +22.5% | 42,331 | +7.7% | 0.00% | – |
Q2 2013 | $253,000 | – | 39,309 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |